Content about Egerkingen

December 12, 2012
Galderma Pharma to acquire Spirig Pharma

Swiss skin drug maker Galderma Pharma will acquire another Swiss drug maker also focused on treatments for skin conditions, Galderma said.

LAUSANNE, Switzerland — Swiss skin drug maker Galderma Pharma will acquire another Swiss drug maker also focused on treatments for skin conditions, Galderma said.

Based in Egerkingen, Switzerland, Spirig makes treatments for such conditions as solar damage and skin barrier function impairment, as well as treatments for such precancerous conditions as actinic keratosis. Financial terms of the deal were not disclosed, though it was noted that Spirig had sales of about $106 million in 2011. The global corporate headquarters of Galderma will remain in Lausanne, Switzerland.

May 24, 2011
Alterna to expand distribution with new trademark, license deal

Alterna, a marketer of personal care products and therapeutic over-the-counter medicines, has signed a new trademark and know-how license agreement with Spirig Pharma AG of Egerkingen, Switzerland, which expands Alterna's exclusive rights to distribute Kerasal one-step exfoliating moisturizing foot ointment to 80 countries outside of North America.

WHIPPANY, N.J. — Alterna, a marketer of personal care products and therapeutic over-the-counter medicines, has signed a new trademark and know-how license agreement with Spirig Pharma AG of Egerkingen, Switzerland, which expands Alterna's exclusive rights to distribute Kerasal one-step exfoliating moisturizing foot ointment to 80 countries outside of North America.

Alterna already owns the Kerasal brand in North America, having fully acquired all rights to trademarks and product technology in 2006.